Claims
- 1. An N-substituted mercaptopropanamide derivative of the formula: ##STR8## wherein R.sub.4 is a C.sub.1 -C.sub.4 alkyl group, and --X--R.sub.3 is ##STR9## or a pharmaceutically acceptable salt thereof.
- 2. The compound according to claim 1, wherein --X--R.sub.3 is ##STR10##
- 3. The compound according to claim 1, wherein R.sub.1 is (C.sub.1 -C.sub.2)alkyl-CO-S.
- 4. The compound according to claim 1, wherein R.sub.1 is propionylthio.
- 5. The compound according to claim 1, wherein R.sub.1 is acetyl thio.
- 6. The compound according to any one of claims 1, 3, 4 or 5, which is 3-[(2-propionyolthiomethyl-3-phenylpropionyl) amino]-5-methylbenzoic acid.
- 7. The compound according to any one of claims 1, 3, 4 or 6, which is 3-[(2-acethylthiomethyl-3-phenylpropionyl) amino]-5-methylbenzoic acid.
- 8. The compound according to any one of claims 1, 3 or 5, which is 3-[(2-acetylthiomethyl-3-phenylpropionyl)amino]-2-methylbenzoic acid.
- 9. The compound according to any one of claims 1, 3, 4 or 6 which is 3-[(2-acetylthiomethyl-3-phenylpropionyl) amino]-5-ethylbenzoic acid.
- 10. A pharmaceutical composition for the treatment of mild to moderate pain, which comprises an effective amount of the compound as set forth in claim 1 in admixture with a pharmaceutically acceptable carrier or diluent.
- 11. The composition according to claim 10, which comprises an effective amount of 3-[(2-propionylthiomethyl-3-phenylpropionyl) amino]-5-methylbenzoic acid in admixture with a pharmaceutically acceptable carrier or diluent.
- 12. A method for the treatment of mild to moderate pain, which comprises administering an effective amount of the compound as set forth in claim 1 to patients suffering from the pain.
- 13. The method according to claim 12, which comprises administering an effective amount of 3-[(2-propionylthiomethyl-3-phenylpropionyl) amino]-5-methylbenzoic acid to patients suffering from the pain.
Priority Claims (2)
Number |
Date |
Country |
Kind |
62-306763 |
Dec 1987 |
JPX |
|
63-200697 |
Aug 1988 |
JPX |
|
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation-in-part application of U.S. Ser. No. 503,969 filed on Apr. 4, 1990, now abandoned which is in turn a continuation-in-part application of U.S. Ser. No. 274,843 filed on Nov. 22, 1988, now abandoned, and of U.S. Ser. No. 504,654 filed on Apr. 4, 1990 now U.S. Pat. No. 5,179,125 which is a divisional application of U.S. Ser. No. 274,843 filed on Nov. 22, 1988 now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4299842 |
Cavazza |
Nov 1981 |
|
4722810 |
Delaney et al. |
Feb 1988 |
|
Foreign Referenced Citations (10)
Number |
Date |
Country |
568628 |
Jan 1988 |
AUX |
890948 |
Feb 1982 |
BEX |
0038046 |
Oct 1981 |
EPX |
0072868 |
Feb 1982 |
EPX |
0115997 |
Aug 1984 |
EPX |
0361365 |
Apr 1990 |
EPX |
2349707 |
Apr 1974 |
DEX |
2372624 |
May 1977 |
FRX |
2556721 |
Dec 1983 |
FRX |
400670A |
Jan 1984 |
ZAX |
Non-Patent Literature Citations (2)
Entry |
B. P. Roques et al., The Enkephalinase Inhibitor Thiorphan Shows Anti-nociceptive Activity in Mice, Nature vol. 288, Nov. 20, 1980, pp. 286-288. |
Derwet Abstract to Roussel-UCLAF, Omega Amino Acid Omega Mercaptopropanamide(s), are Enkephalinase Inhibitors, Useful as Analgesics (Dec. 14, 1983). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
274843 |
Nov 1988 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
503969 |
Apr 1990 |
|
Parent |
274843 |
Nov 1988 |
|